Insights Navigating Uncertainty: A Strategic Framework for Biotech CEOs in Challenging Markets Kim Kraemer Apr 16, 2025
Insights Today’s Biotech IPO is the Departure Point: Not the Destination: A view from inside the 2026 Biotech IPO resurgence Terri Clevenger May 27, 2026 READ MORE
Insights Diane Weiser Leads the Way. The Communicator Who Bet on Patients – and Grew Alongside Them. Kim Kraemer May 26, 2026 READ MORE
Insights From Pivot to Payout: How Blueprint Medicines Navigated a $9.5B Exit Kim Kraemer Dec 09, 2025 READ MORE
In the News What Boards Really Mean When They Demand ‘Awareness’ Terri Clevenger Oct 09, 2025 READ MORE
Insights The Reputation Constant: Dr. John Scarlett on Leading Biotech Through Change Kim Kraemer Oct 07, 2025 READ MORE
In the News Getting to Yes: How Deal-Making Fuels Biotech Growth Waterhouse Brands Sep 17, 2025 READ MORE
Insights Sunsetting the Mission, Preserving the Light: How Reputation Outlives the Molecule Terri Clevenger Aug 27, 2025 READ MORE